84 related articles for article (PubMed ID: 3300775)
41. [Studies on phosphorylation of estrogen receptor from porcine uterus].
Ishibe Y
Hokkaido Igaku Zasshi; 1993 Sep; 68(5):728-35. PubMed ID: 8225178
[TBL] [Abstract][Full Text] [Related]
42. Structural requirements for high affinity ligand binding by estrogen receptors: a comparative analysis of truncated and full length estrogen receptors expressed in bacteria, yeast, and mammalian cells.
Wooge CH; Nilsson GM; Heierson A; McDonnell DP; Katzenellenbogen BS
Mol Endocrinol; 1992 Jun; 6(6):861-9. PubMed ID: 1495491
[TBL] [Abstract][Full Text] [Related]
43. Mapping on the calf estrogen receptor of the binding domain for an antibody interfering with receptor activation.
Fauque J; Scali J; Cavaillés V; Borgna JL
J Steroid Biochem; 1989 Jun; 32(6):769-80. PubMed ID: 2755125
[TBL] [Abstract][Full Text] [Related]
44. Modulation of the estrogen receptor structure, evidence of a heterogeneity.
Toulas C; Guilbaud N; Delassus F; Bayard F; Faye JC
J Recept Res; 1990; 10(1-2):1-9. PubMed ID: 2262930
[TBL] [Abstract][Full Text] [Related]
45. Characterization of molybdate-stabilized estrogen receptors by hydrophobic interaction HPLC: resolution of two 8S subunits.
Madhok TC; Leung BS; Stout LE
Horm Res; 1987; 25(1):29-36. PubMed ID: 3817756
[TBL] [Abstract][Full Text] [Related]
46. Characterization of rabbit uterine estrogen receptor proteins by radioiodination and partial peptide mapping.
Olsen MR; Van Oosbree TR; Mueller GC
Endocrinology; 1986 Nov; 119(5):2177-85. PubMed ID: 3533522
[TBL] [Abstract][Full Text] [Related]
47. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
Bouhoute A; Leclercq G
Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
[TBL] [Abstract][Full Text] [Related]
48. [In vivo occupation of estrogen receptors by hydroxylated metabolites of tamoxifen].
Borgna JL; Rochefort H
C R Seances Acad Sci D; 1979 Dec; 289(15):1141-4. PubMed ID: 121266
[TBL] [Abstract][Full Text] [Related]
49. 4-iodotamoxifen aziridine, a new affinity labeling agent for the rapid detection of estrogen receptor isoforms.
Maaroufi Y; Quivy J; Trivedi S; Gilot N; Leclercq G
J Steroid Biochem Mol Biol; 1998 Oct; 67(2):95-104. PubMed ID: 9877209
[TBL] [Abstract][Full Text] [Related]
50. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
Bronzert DA; Greene GL; Lippman ME
Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
[TBL] [Abstract][Full Text] [Related]
51. Subunit structure of the nonactivated human estrogen receptor.
Segnitz B; Gehring U
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2179-83. PubMed ID: 7892243
[TBL] [Abstract][Full Text] [Related]
52. Evolution towards hormone independence of the MXT mouse mammary tumor is associated with a gradual change in its estrogen receptor molecular polymorphism.
Piccart MJ; Trivedi S; Maaroufi Y; Debbaudt A; Veenstra S; Leclercq G
Cancer Biochem Biophys; 1998 Jun; 16(1-2):169-82. PubMed ID: 9923975
[TBL] [Abstract][Full Text] [Related]
53. Target size analysis of estrogen receptor in cultured intact cells: change in receptor structure between subconfluency and superconfluency in culture.
Toulas C; Beauregard G; Delassus F; Thauvette L; Potier M; Bayard F; Faye JC
Mol Cell Endocrinol; 1990 Aug; 72(2):89-94. PubMed ID: 2282975
[TBL] [Abstract][Full Text] [Related]
54. Proteolytic fragments of the receptors for IgE.
Roth PA; Froese A
Immunol Lett; 1982 Mar; 4(3):159-65. PubMed ID: 6210630
[TBL] [Abstract][Full Text] [Related]
55. Estrogen-like activity of a subpopulation of natural antiestrogen receptor autoantibodies in man.
Borkowski A; Gyling M; Muquardt C; Body JJ; Leclercq G
Endocrinology; 1991 Jun; 128(6):3283-92. PubMed ID: 2036991
[TBL] [Abstract][Full Text] [Related]
56. Comparison of tritiated estradiol and tamoxifen aziridine for measurement of estrogen receptors in human breast cancer cytosols.
Piccart MJ; Muquardt C; Bosman C; Pirotte P; Veenstra S; Grillo F; Leclercq G
J Natl Cancer Inst; 1991 Nov; 83(21):1553-9. PubMed ID: 1960752
[TBL] [Abstract][Full Text] [Related]
57. Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.
MacGregor Schafer J; Liu H; Bentrem DJ; Zapf JW; Jordan VC
Cancer Res; 2000 Sep; 60(18):5097-105. PubMed ID: 11016635
[TBL] [Abstract][Full Text] [Related]
58. Hydrodynamic characterizations of estrogen receptors complexed with [3H]-4-hydroxytamoxifen: evidence in support of contrasting receptor transitions mediated by different ligands.
Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Hanson MB; Gallion H; Flanigan RC; Kenady DE
Biochemistry; 1985 Dec; 24(27):8101-6. PubMed ID: 4092059
[TBL] [Abstract][Full Text] [Related]
59. Surface mapping of the ligand-filled C-terminal half of the porcine estradiol receptor by restricted proteolysis.
Thole HH; Maschler I; Jungblut PW
Eur J Biochem; 1995 Jul; 231(2):510-6. PubMed ID: 7635163
[TBL] [Abstract][Full Text] [Related]
60. The nature and significance of multiple isoforms of the oestrogen receptor in breast tumours.
Puddefoot JR; Baker VA; Bakkers B; Marsigliante S; Barker S; Panahy C; Goode AW; Carpenter R; Vinson GP
J Mol Endocrinol; 1993 Aug; 11(1):83-90. PubMed ID: 8240675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
